---
title: "AMRX: Q2 revenue and profit surged, outlook raised, and biosimilar expansion accelerates with Kashiv"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294381748.md"
description: "Q2 2026 saw double-digit revenue and profit growth, driven by strong performance in affordable medicines, specialty, and biosimilars. The pending Kashiv acquisition will create a fully integrated biosimilar platform, while guidance for 2026 was raised across all key metrics.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T14:21:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294381748.md)
  - [en](https://longbridge.com/en/news/294381748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294381748.md)
generator: "portal-rs"
---

# AMRX: Q2 revenue and profit surged, outlook raised, and biosimilar expansion accelerates with Kashiv

Q2 2026 saw double-digit revenue and profit growth, driven by strong performance in affordable medicines, specialty, and biosimilars. The pending Kashiv acquisition will create a fully integrated biosimilar platform, while guidance for 2026 was raised across all key metrics.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AMRX.US](https://longbridge.com/en/quote/AMRX.US.md)

## Related News & Research

- [Amneal Pharmaceuticals (NASDAQ:AMRX) Receives "Overweight" Rating from JPMorgan Chase & Co.](https://longbridge.com/en/news/297060385.md)
- [Sell Alert: Nikita Shah Cashes Out $2.56M In Amneal Pharmaceuticals Stock](https://longbridge.com/en/news/295951572.md)
- [Lexaria says DehydraTECH 3.0 retatrutide tablet boosts absorption up to 4,552% in dog study](https://longbridge.com/en/news/296793626.md)
- [Quest Diagnostics teams with Humanity to offer biological age analysis on Questhealth.com](https://longbridge.com/en/news/296926398.md)
- [Is Gilead (GILD) Using AI Tissue Analytics To Quietly Redefine Its Oncology Edge?](https://longbridge.com/en/news/296706386.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**